Navigation Links
New research could pave the way to safer treatments for arthritis
Date:7/4/2013

The increased risk of heart attack or stroke associated with many arthritis drugs may be avoidable, according to a new international study co-authored by researchers at Imperial College London.

Drugs such as Vioxx, diclofenac, ibuprofen and Celebrex operate by blocking an enzyme known as COX-2, whose presence in blood vessels has up until now been held responsible for these side effects. New research carried out on mice has revealed that COX-2 is largely absent from the major blood vessels and instead found in the brain, gut, and kidney as well as the thymus gland in the chest.

Now that researchers know where in the body the drug is acting, they can begin to develop safer, more targeted drugs for patients with arthritis as well as cancer.

Arthritis drugs have long been associated with potentially fatal cardiovascular side-effects in patients. Health concerns led to the anti-inflammatory Vioxx being withdrawn from the market in 2004, and this week medical regulators have advised some patients to stop using the painkiller diclofenac.

Researchers have always believed that COX-2 was found in the blood vessels where it was central to preventing the formation of clots. This meant that any drug that inhibited the enzyme was thought to lead to an increased risk of clotting.

The new study, published today in the journal PLOS ONE, reveals that COX-2 is largely absent from the major blood vessels. Instead COX-2 appears to be present in the brain, kidney, thymus and gut, where it may well be affecting the cardiovascular health.

Lead author, Professor Jane Mitchell of Imperial's Faculty of Medicine said: "Now we know the true sites of COX-2, we can begin to develop new ideas that will lead to better drugs for arthritis and cancer with fewer side effects."

The new research suggests future development of COX-2 inhibitors that carry reduced risk of stroke or heart attack may be possible. Professor Mitchell
'/>"/>

Contact: Gilead Amit
gda07@imperial.ac.uk
Imperial College London
Source:Eurekalert

Page: 1 2

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. NIH awards $20 million over 5 years to train next generation of global health researchers
3. Researchers develop a new cell and animal model of inflammatory breast cancer
4. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
5. Sexually abused boys at risk for more unsafe sex: UBC research
6. Researchers Find Gene Mutations That May Be a Key to Autism
7. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
8. Researchers find evidence of banned antibiotics in poultry products
9. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
10. Scientific session and new research highlights
11. NJ stroke researchers report advances in spatial neglect research at AAN Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... California (PRWEB) February 28, 2015 ... supported and showcased emerging brand at Houston Texas ... in Las Vegas sending its executive delegates headed ... of Business Development and Training Randolph Clarito. , ... (IFA), was held last February 4-7 and featured ...
(Date:2/27/2015)... A new study published in the Journal ... cycle on a regular basis and prostate cancer. While cycling ... the more hours per week a man spends cycling, the ... an increased importance on prostate cancer screening methods. , “This ... closely at patents’ risk factors for developing prostate cancer,” says ...
(Date:2/27/2015)... 27, 2015 On March 2-4, ... the National Cancer Institute (NCI) will co-host the ... National Institutes of Health (NIH), in Bethesda, Maryland. ... dedicated to medical professionals and scientists who specialize ... the general public, including patients, their families, and ...
(Date:2/27/2015)... Pipette.com announces their limited time pricing on ... valid until the end of March 2015. The Vortex-Genie ... mixer that allows for absolute control and true vortexing. ... is headquartered in Bohemia, New York. Scientific Industries manufactures ... other rockers, incubators, and hybridization ovens which are made ...
(Date:2/27/2015)... NC (PRWEB) February 27, 2015 The ... leading cancer research funding organizations, is excited to announce ... ways to participate and many long-standing partnerships highlight The ... and focus on expanding ways for all to get ... donations to cutting-edge cancer research, The V Foundation has ...
Breaking Medicine News(10 mins):Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 3Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 3Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 2Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 3Health News:Pipette.com Announces Limited Time Offer of 24% Off List Price on the Vortex-Genie 2 2Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 2Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 3
... 20 Pressure BioSciences, Inc. (Nasdaq: PBIO ... on various corporate activities, including (1) the receipt of ... from the National Institutes of Health ("NIH"), (2) a ... School of Public Health on the significant advantages ...
... Nuvilex, Inc. (OTC Bulletin Board: NVLX), formerly eFoodSafety.com, Inc. (OTC ... conference call held on March 19, 2009 at 4:30 p.m. ... at 7:30 PM ET to March 26, 2009 at 11:59 ... 1-201-612-7415 (international). To listen to the replay, please provide ...
... SANTA MONICA, Calif., March 20 Cord Blood America, ... cord blood stem cell storage company, has selected Somerville ... West Los Angeles as public relations counsel for Cord ... and CEO of Cord Blood America. The agency ...
... indicates that some aspects of peoples, cognitive skills such ... and detect relationships peak at about the age of ... 27. , "This research suggests that some aspects of age-related ... in their 20s and 30s," said Timothy Salthouse, a University ...
... 20 , - On Average a ... and Poland Claim Worsening Quality of Sleep,Thanks to the Economy(1) , ... Making the Admission, Compared,to 17% of the UK(1) , ... Problems Sleeping,Over the Last 12 Months, but Only 19% of These ...
... the Society for Human Resource Management reports that ... sexual harassment policy, a recent University of Missouri ... effective in preventing workplace harassment. Researchers in the ... way individuals define and explain their understanding of ...
Cached Medicine News:Health News:Pressure BioSciences, Inc. Provides Corporate Update 2Health News:Pressure BioSciences, Inc. Provides Corporate Update 3Health News:Pressure BioSciences, Inc. Provides Corporate Update 4Health News:Pressure BioSciences, Inc. Provides Corporate Update 5Health News:Nuvilex Provides Conference Call Replay Information 2Health News:Cord Blood America, Inc. Appoints Somerville Associates, Public Relations Counsel 2Health News:Cognitive decline begins in late 20s, study suggests 2Health News:New Survey Highlights the Significant Impact of the Economic Downturn on Europe's Sleep 2Health News:New Survey Highlights the Significant Impact of the Economic Downturn on Europe's Sleep 3Health News:New Survey Highlights the Significant Impact of the Economic Downturn on Europe's Sleep 4Health News:New Survey Highlights the Significant Impact of the Economic Downturn on Europe's Sleep 5Health News:Perceptions of similar language may prevent understanding of sexual harassment policies 2
(Date:2/27/2015)... LONDON , February 27, 2015 ... - new study showing you trends, R&D progress, and ... medicine heading? What are the commercial prospects for ... shows you potential revenues and other trends to 2025, ... ,s report lets you assess regenerative medicine : ...
(Date:2/27/2015)... -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today ... the fourth quarter and full year ended December 31, ... for PTC. We are now a growing commercial-stage biopharma ... the rare disease space," stated Stuart W. Peltz, Ph.D., ... to bring the first treatment for Duchenne muscular dystrophy ...
(Date:2/27/2015)... Feb. 27, 2015  Bionik Laboratories Corp. (OTC:DWTPD), a ... today that it acquired Bionik Laboratories, Inc., a ... the sale to qualified accredited investors of units consisting ... proceeds of approximately $6.2 million. Shares of the Company,s ... OTC Markets under the symbol "DWTPD" until FINRA,s approval ...
Breaking Medicine Technology:Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: